Kaltoft Mette Kjer, Nielsen Jesper Bo, Dowie Jack
Odense University Hospital Svendborg, Denmark.
University of Southern Denmark, Denmark.
Stud Health Technol Inform. 2018;251:23-26.
Accelerating progress in screening technologies, e.g. genetic testing, means more individuals are facing the stressful decision of whether to request the test. Fully-informed and preference-based consent, as well as ethical practice, requires the full range of benefits and harms from any test or treatment to be identified and assessed from the individual's point of view. For both ethical and legal reasons, we see the decision on whether to undertake a genetic screening test being increasingly seen, in future, as calling for a personalised analysis of the full range of subsequent management options. The conventional dissociation of 'risk assessment' and 'risk management' phases is thereby ruled out. One way of addressing the resulting challenge is through personalised multi-criterial decision support tools. In this vision paper we provide conceptual proof of method of how such an interactive online tool could function. The polygenetic genetic screening decision is used, solely as illustration.
筛查技术(如基因检测)的加速发展意味着越来越多的人面临是否要求进行检测这一压力重重的决定。充分知情且基于偏好的同意,以及道德实践,要求从个人角度识别和评估任何检测或治疗的所有益处和危害。出于伦理和法律原因,我们认为未来关于是否进行基因筛查检测的决定将越来越需要对后续所有管理选项进行个性化分析。因此,传统的“风险评估”和“风险管理”阶段的分离被排除。应对由此产生的挑战的一种方法是通过个性化的多标准决策支持工具。在这篇展望论文中,我们提供了一个概念性的方法证明,说明这样一个交互式在线工具可以如何运作。多基因基因筛查决策仅用作示例。